Search

everythinglearnresearchcommunity

for

Search:↓

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

Young women with PCOS and no other heart risk factors have normal heart function.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Bariatric surgery is safe and effective for treating adolescent obesity.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.